Faeth Therapeutics Inc.
FTH | NASDAQ
$18.73
+$0.04 (+0.21%)
Nov 2, 2026, 12:04 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -4.85M | -4.85M | -4.85M | -4.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 128.11M | 128.11M | -4.85M | -4.71M | 279K | 414K | 551K | 547K | 862K | 1.22M | 1.08M | 1.42M | 1.41M | 1.36M | 1.81M | 1.67M | 1.35M | 1.04M | 685K | 356K | 220K | 150K |
Gross Profit | -132.96M | -132.96M | n/a | -139K | -279K | -414K | -551K | -547K | -862K | -1.22M | -1.08M | -1.42M | -1.41M | -1.36M | -1.81M | -1.67M | -1.35M | -1.04M | -685K | -356K | -220K | -150K |
Operating Income | -198.82M | -185.64M | -22.29M | -24.65M | -27.63M | -30.21M | -31.66M | -32.48M | -32.4M | -34.79M | -37.07M | -40.91M | -47.11M | -47.64M | -49.12M | -46.55M | -42.93M | -42M | -37.48M | -33.15M | -28.19M | -23.32M |
Interest Income | 3.16M | 1.23M | 1.24M | 1.54M | 1.84M | 2.19M | 2.55M | 2.85M | 3.14M | 3.42M | 3.62M | 3.41M | 3.05M | 2.44M | 1.78M | 1.51M | 1.27M | 1.11M | 800K | 466K | 188K | n/a |
Pretax Income | -195.53M | -184.46M | -21.09M | -24.14M | -26.82M | -29.03M | -30.16M | -29.8M | -29.67M | -31.92M | -34.1M | -38.92M | -45.21M | -46.36M | -48.59M | -45.72M | -41.99M | -41.23M | -36.79M | -32.56M | -28.24M | -23.38M |
Net Income | -195.53M | -184.46M | -21.09M | -24.14M | -26.82M | -29.03M | -30.16M | -29.8M | -29.67M | -31.92M | -34.1M | -38.92M | -45.21M | -46.36M | -48.59M | -45.72M | -41.99M | -41.23M | -36.79M | -32.56M | -28.24M | -23.38M |
Selling & General & Admin | 34.02M | 27.49M | 11.33M | 11.23M | 11.96M | 12.36M | 12.49M | 13.3M | 13.72M | 15.86M | 17.99M | 19.44M | 20.28M | 18.95M | 17.73M | 15.89M | 15.33M | 15.21M | 15.14M | 14.53M | 12.58M | 10.07M |
Research & Development | 31.84M | 25.19M | 10.96M | 13.28M | 15.38M | 17.44M | 18.63M | 18.63M | 17.81M | 17.71M | 18M | 20.05M | 25.42M | 27.33M | 29.58M | 28.99M | 26.25M | 25.75M | 21.66M | 18.26M | 15.4M | 13.09M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 65.86M | 52.68M | 22.29M | 24.52M | 27.35M | 29.79M | 31.11M | 31.94M | 31.53M | 33.58M | 35.99M | 39.5M | 45.7M | 46.28M | 47.31M | 44.89M | 41.58M | 40.97M | 36.8M | 32.79M | 27.97M | 23.17M |
Interest Expense | 9K | 19K | 32K | 46K | 61K | 75K | 90K | 104K | 116K | 130K | 144K | 113K | 90K | 224K | 425K | 731K | 935K | 910K | 670K | 418K | 207K | 63K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -137K | -137K | -137K | -137K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 193.97M | 180.79M | 17.44M | 19.8M | 27.63M | 30.21M | 31.66M | 32.48M | 32.4M | 34.79M | 37.07M | 40.91M | 47.11M | 47.64M | 49.12M | 46.55M | 42.93M | 42M | 37.48M | 33.15M | 28.19M | 23.32M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.64M | 1.3M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.25M | 1.25M | 1.28M | 1.53M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.53M | 1.53M | 1.53M | 1.53M |
Shares Outstanding (Diluted) | 5.64M | 1.3M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M | 1.25M | 1.25M | 1.28M | 1.53M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.53M | 1.53M | 1.53M | 1.53M |
EPS (Basic) | -141.65 | -142.72 | -16.72 | -19.16 | -21.31 | -23.09 | -24.02 | -23.76 | -23.57 | -24.03 | -24.24 | -26.28 | -29.43 | -30.14 | -31.65 | -29.81 | -27.41 | -26.94 | -24.05 | -21.28 | -18.46 | -15.28 |
EPS (Diluted) | -141.65 | -142.72 | -16.72 | -19.16 | -21.31 | -23.09 | -24.02 | -23.76 | -23.57 | -24.03 | -24.24 | -26.28 | -29.43 | -30.14 | -31.65 | -29.81 | -27.41 | -26.94 | -24.05 | -21.28 | -18.46 | -15.28 |
EBITDA | -195.4M | -184.3M | -20.92M | -23.85M | -26.41M | -28.51M | -29.52M | -29.15M | -28.69M | -30.57M | -32.52M | -37.03M | -43.35M | -44.42M | -46.36M | -43.32M | -39.7M | -39.28M | -35.44M | -31.72M | -27.68M | -23.03M |
EBIT | -195.52M | -184.44M | -21.05M | -24.09M | -26.76M | -28.95M | -30.07M | -29.7M | -29.56M | -31.79M | -33.96M | -38.81M | -45.12M | -46.14M | -48.16M | -44.99M | -41.06M | -40.32M | -36.12M | -32.14M | -28.03M | -23.32M |
Depreciation & Amortization | 123K | 135K | 139K | 244K | 350K | 448K | 551K | 547K | 862K | 1.22M | 1.44M | 1.77M | 1.77M | 1.72M | 1.81M | 1.67M | 1.35M | 1.04M | 685K | 426K | 354K | 284K |
Add to Watchlist
Select watchlists to add or remove FTH